Global Antidiabetics Market will grow at a CAGR of more than 9.5% during the forecast period by 2022

1
Global Antidiabetics Market Research Report

• Presented By
• Market Research Engine
• http//marketresearchengine.com/

2
Report TitleGlobal Antidiabetics Market will
grow at a CAGR of more than 9.5 during the
forecast period by 2022
3

• New York, May 29 Market Research Engine has
  published a new report titled as Antidiabetics
  Market - Global Industry Analysis, Size, Share,
  Growth, Trends, and Forecast 2015 - 2022
• Ant diabetics are the drugs which stabilize the
  glucose levels in blood. These medicines also
  control and lower the levels of glucose in blood
  for diabetic patients. Most common type of
  antidiabetics is insulin. A periodic shot of
  insulin generally long acting type is prescribed
  for diabetic patients to regulate glucose
  levels. 
• Browse Full Report http//www.marketresearchengi
  ne.com/reportdetails/antidiabetics-market
• Increasing number of diabetic patients is
  increasing the demand for antidiabetics which is
  a driving factor for antidiabetics market.
  Increased use of insulin is a growth factor for
  this market. Insulin leads the global market with
  the largest market share by revenue and
  anticipated to have sharp growth. Increase in
  rates of obesity is obliquely driving the
  antidiabetics market. North America hold the
  largest share in antidiabetics market as it holds
  highest rate of obesity in the world, which is
  one of the major reason for cause of diabetics.

4

• The global antidiabetics market was valued at USD
  41,305.7 million in 2013 and is expected to grow
  at a CAGR of more than 9.5 during the forecast
  period.
•  
• The global antidiabetics market is segmented
  based on its product which includes
  thiazolodinediones, glp-agonists, sulphonylureas,
  dpp-4 inhibitors, sglt-2, alpha-glucosidase
  inhibitors, biguanides and meglitinides. The
  insulin is segmented as rapid acting, long
  acting, premixed, premixed analog, short acting
  and intermediate acting. The market segments in
  terms of geographical regions include North
  America, Europe, Asia-Pacific and Rest of the
  World (ROW).
• This report provides 
• 1) An overview of the global market for
  antidiabetics and related technologies.
•  
• 2) Analyses of global market trends, with data
  from 2013, estimates for 2014 and 2015, and
  projections of compound annual growth rates
  (CAGRs) through 2023.
• 3) Identifications of new market opportunities
  and targeted promotional plans for acetic acid
  market.

5

• 4) Discussion of research and development, and
  the demand for new products and new applications.
•  
• 5) Comprehensive company profiles of major
  players in the industry. 
•  
• REPORT SCOPE 
• The scope of the report includes a detailed study
  of global and regional markets for various types
  of coatings with the reasons given for variations
  in the growth of the industry in certain regions.
• The report covers detailed competitive outlook
  including the market share and company profiles
  of the key participants operating in the global
  market. Key players profiled in the report
  include Sanofi-Aventis, Eli Lilly, Oramed
  Pharmaceuticals, Boehringer Ingelheim, Merck
  Co. Inc., Bristol-Myers Squibb, Novo Nordisk,
  Halozyme Therapeutics, Pfizer and Takeda
  Pharmaceuticals. Company profile includes assign
  such as company summary, financial summary,
  business strategy and planning, SWOT analysis and
  current developments. 

6

• The Antidiabetics Market has been segmented as
  below  
•  
• By Types of Insulin
•  
• Rapid Acting
• Long Acting
• Premixed
• Premixed Analog
• Short Acting
• Intermediate Acting
• By Product
•  
• Biguanides
• Thiazolodinediones
• GLP-agonists
• Sulphonylureas

7

• DPP-4 inhibitors
• SGLT-2
• Alpha-glucosidase Inhibitors
• Meglitinides
• By Geography
•  
• North America
• Europe
• Asia-Pacific
• Rest of the World (ROW)

8

• 
  Table of Contents
• TABLE OF CONTENT
• Chapter 1. Executive Summary
• 1.1. AntidiabeticsIndustry Summary and Critical
  Success Factors (CSFs)
• Chapter2. Antidiabetics Industry Outlook
• 2.1. Market Segmentation
• 2.2. Market sizeand growth prospects
• 2.3. Antidiabetics Market dynamics
• 2.3.1. Market driver analysis
• 2.3.1.1 Growing prevalence of diabetes
• 2.3.1.2 Presence of a strong product pipeline
  portfolio
• 2.3.1.3 Growing prevalence of lifestyle induced
  disorderssuch as obesity
• 2.3.2. Market Restraint Analysis
• 2.3.2.1. High insulin prices
• 2.4. KeyOpportunities Prioritized
• 2.5. IndustryAnalysis Porters

9

• 2.7 Antidiabeticsmarket Pipeline overview
• Chapter3 . Antidiabetics Product Outlook
• 3.1. Antidiabeticsmarket share by product, 2013
  2020
• 3.2. Insulin
• 3.2.1. Insulin market share, by product, 2013
  2020
• 3.2.2. Rapid acting analog market
• 3.2.2.1. Rapid acting analog market, 2012 2020
  (USDMillion)
• 3.2.3. Long acting analog market
• 3.2.3.1 Long acting analog market, 2012 2020
  (USD Million)
• 3.2.4. Premixed analog market
• 3.2.4.1 Premixed analog market, 2012 2020 (USD
  Million)
• 3.2.5. Premixed insulin market
• 3.2.5.1. Premixed insulin market, 2012 2020
  (USD Million)
• 3.2.6. Short acting insulin market
• 3.2.6.1. Short acting insulin market, 2012
  2020 (USDMillion)
• 3.2.7. Intermediate acting insulin market
• 3.2.7.1 Intermediate acting insulin market, 2012
  2020 (USDMillion)
• 3.3. Otherantidiabetics

10

• 3.5. Biguanides
• 3.5.1. Biguanides market, 2012 2020 (USD
  Million)
• 3.6. Sulphonylureas
• 3.6.1. Sulphonylureas market, 2012 2020 (USD
  Million)
• 3.7. GLP 1 (Glucagon like peptide) agonists
• 3.7.1. GLP 1 agonist market, 2012 2020 (USD
  Million)
• 3.8. DPP - 4(Dipeptyl peptides) inhibitors
• 3.8.1. DPP-4 market, 2012 2020 (USD Million)
• 3.9. Meglitinides
• 3.9.1. Meglitinidesmarket, 2012 2020 (USD
  Million)
• 3.10. SGLT - 2(sodium glucose transport
  proteins) inhibitors
• 3.10.1. SGLT - 2 inhibitors market, 2012 2020
  (USD Million)
• 3.11. Thiazolodinediones
• 3.11.1. Thiazolodinediones market, 2012 2020
  (USD Million)
• Chapter4. Antidiabetics Regional Outlook
• 4.1. Antidiabeticsmarket share, by region, 2013
  2020
• 4.2. North America antidiabetics market
• 4.2.1. North America antidiabetics market, 2012
  2020 (USD Million)

11

• 4.4. Asia Pacificantidiabetics market
• 4.4.1. Asia Pacific antidiabetics Market, 2015
  2023(USD Million)
• 4.5. RoWantidiabetics market
• 4.5.1. RoW antidiabetics market, 2015 2023 (USD
  Million)
• Chapter5. Competitive Landscape
• 5.1 Sanofi Aventis
• 5.1.1Company Overview
• 5.1.2Financial Performance
• 5.1.3Product Benchmarking
• 5.1.4Strategic Initiatives
• 5.2 TakedaPharmaceuticals
• 5.2.1Company Overview
• 5.2.2Financial Performance
• 5.2.3Product Benchmarking
• 5.2.4Strategic Initiatives
• 5.3 Eli Lilly
• 5.3.1Company Overview
• 5.3.2Financial Performance

12

• 5.4 OramedPharmaceuticals Inc.
• 5.4.1Company Overview
• 5.4.2Financial Performance
• 5.4.3Product Benchmarking
• 5.4.4Strategic Initiatives
• 5.5 Merck Co. Inc.
• 5.5.1Company Overview
• 5.5.2Financial Performance
• 5.5.3Product Benchmarking
• 5.5.4Strategic Initiatives
• 5.6 Novo Nordisk
• 5.6.1Company Overview
• 5.6.2 FinancialPerformance
• 5.6.3Product Benchmarking
• 5.6.4Strategic Initiatives
• 5.7 Bristol-Myers Squibb
• 5.7.1Company Overview
• 5.7.2Financial Performance
• 5.7.3Product Benchmarking

13

• 5.8.1Company Overview
• 5.8.2Financial Performance
• 5.8.3Product Benchmarking
• 5.8.4Strategic Initiatives
• 5.9 Pfizer
• 5.9.1Company Overview
• 5.9.2Financial Performance
• 5.9.3Product Benchmarking
• 5.9.4Strategic Initiatives
• Check Out Other Research Reports
• 5G Technology Market - Global Industry Analysis,
  Size, Share, Growth, Trends and Forecast 2015 -
  2023 http//www.marketresearchengine.com/reportdet
  ails/5g-technology-market
• Acetic Acid Market for VAM, PTA, Acetate Esters,
  Acetic Anhydride and Other Applications - Global
  Industry Analysis, Size, Share, Growth, Trends
  and Forecast, 2015 - 2023 http//www.marketresearc
  hengine.com/reportdetails/acetic-acid-market

14

• About Market Research Engine
• Market Research Engine is a global market
  research and consulting organization. We provide
  market intelligence in emerging, niche
  technologies and markets. Our market analysis
  powered by rigorous methodology and quality
  metrics provide information and forecasts across
  emerging markets, emerging technologies and
  emerging business models. Our deep focus on
  industry verticals and country reports help our
  clients to identify opportunities and develop
  business strategies.
• More info http//marketresearchengine.com/
• Media Contact
• Name John Bay
• Toll Free No. 1-855-984-1862
• Phone [phone]
• Email john_at_marketresearchengine.com
• Website http//marketresearchengine.com/